Cancer
Conditions
Interventions
Participants will be allocated to one of the three arms: 1. PROACT 2.0 video,
2. the PROACT 2.0 digital questionnaire, and 3. standard QoL monitoring. All
arms will last for 4 weeks.
Sponsors
Antoni van Leeuwenhoek Ziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Screening for participation in a phase 1-2 anticancer drug trials. 2. Written informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Not capable of using mobile phone applications, or no carer who is willing to and able to use the applications on the participants behalf. 2. Enrolled in a phase 1-2 anticancer drug trial that includes a QoL questionnaire, where inclusion of an additional QoL would interfere with the study*s intended QoL measurements. This is at the investigator*s discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the feasibility of using digital tools to report effects of drugs in patients on phase 1 or 2 anticancer drug trials. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate user experience of using different digital tools to self-report on adverse events and quality of life. | — |
Countries
Netherlands
Outcome results
None listed